Home
About
FAQ
History (18)
Evaluation of cerebrospinal clonal gene rearrangement in newly diagnosed non-Hodgkin's lymphoma patients.
Suppressing the activation of protein kinase A as a DNA damage-independent mechanistic lead for dihydromethysticin prophylaxis of NNK-induced lung carcinogenesis.
Risky Behavior: Hospital Transfers Associated with Early Mortality and Rates of Goals of Care Discussions.
"Now We Are Seeing the Tides Wash In": Trauma and the Opioid Epidemic in Rural Appalachian Ohio.
Social support modifies the association between hazardous drinking and depression symptoms among ART clients in Vietnam.
See All 18 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Results (18)
More Search Options
Sort
Query Relevance
Name (A-Z)
Name (Z-A)
Institution (A-Z)
Institution (Z-A)
Show
(choose columns)
Faculty Rank
Name
Institution
Why
Steven R. Feldman MD, PhD
Wake Forest School of Medicine
Why?
Michael A. Nader PhD
Wake Forest School of Medicine
Why?
Roger M. Vilardaga Viera
Why?
Joseph A. Skelton MD, MS
Wake Forest School of Medicine
Why?
Eric C. Donny PhD
Wake Forest School of Medicine
Why?
Paul Czoty PhD
Wake Forest School of Medicine
Why?
Sara Jones PhD
Wake Forest School of Medicine
Why?
Kathryn E. Lancaster PhD, MPH
Wake Forest School of Medicine
Why?
Stephen R. Rapp PhD
Wake Forest School of Medicine
Why?
Robert W. Gould PhD
Wake Forest School of Medicine
Why?
Allyn Howlett PhD
Wake Forest School of Medicine
Why?
Sarah L. Taylor MD, MPH
Wake Forest School of Medicine
Why?
Brian A. McCool PhD
Wake Forest School of Medicine
Why?
Robert W. Hurley MD, PhD
Wake Forest School of Medicine
Why?
Paul J. Laurienti MD, PhD
Wake Forest School of Medicine
Why?
Per Page
15
25
50
100
Page
of 2
Next
Prev
Search Criteria
Behavior Addictive
Click "Why?" to see why a person matched the search.
Search Options
Modify Search
Search Other Institutions